Quick News Bit

APEC to debate proposal to remove tariffs for COVID vaccines, medical prodcuts By Reuters

0
© Reuters. FILE PHOTO: A batch of Johnson & Johnson’s Janssen coronavirus disease (COVID-19) vaccines arrives at a military airport in Seongnam, South Korea, June 5, 2021. REUTERS/Kim Hong-Ji/Pool

MELBOURNE (Reuters) – Ministers from Asia-Pacific trade group APEC are set to discuss on Saturday a proposal from New Zealand to remove tariffs on COVID-19 vaccines and related medical products, although some members consider the plan to be too ambitious.

In a move that could ease delays in delivering vaccines more widely, host New Zealand wants APEC’s 21 members to agree on “best practices guidelines” on the movement of vaccines and related medical products across borders, a person familiar with the talks told Reuters.

New Zealand believes an agreement is needed to show that APEC is responsive and relevant to the crisis facing the world.

Average APEC tariffs on vaccines are low at around 0.8% but other goods important in the vaccine supply chain face higher tariffs.

Alcohol solutions, freezing equipment, packaging and storage materials, vials and rubber stoppers face average tariff rates above 5%, and import tariffs can be as high as 30% in some APEC economies.

Senior officials have been in talks since May 18 and trade ministers will hold final discussions in a virtual meeting later on Saturday after which a joint statement will be issued.

APEC gatherings in recent years have struggled to reach agreements due to then-U.S. President Donald Trump’s trade war with China. The new Biden administration has promised a more multilateral approach.

APEC ministers are also expected to discuss support for the waiving of intellectual property rights for COVID-19 vaccines, an issue which is currently under negotiation at the World Trade Organization. India and South Africa are leading the push for waivers.

In a surprise shift in May, the United States moved to support a patent waiver, putting pressure on opponents like the European Union and Switzerland, where several drugmakers are based.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

For all the latest Business News Click Here 

 For the latest news and updates, follow us on Google News

Read original article here

Denial of responsibility! NewsBit.us is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.

Leave a comment